Service-De-Piscine-R-D-R near Richer MB (34 Result(s))

ContactEnhanced Accelerator ModelFounded in 1997 by renowned bio-entrepreneur Dr. Albert D. Friesen, the GVI team has extensive experience in technology development to offer its clients. The Company provides services to client companies through an enhanced accelerator model and active participation. GVI takes the idea of an incubator to the next level, becoming actively involved with each new venture and offering a tailored mix of services vital to successfully develop a technology that will address market opportunities.State of the ArtGVI believes that entrepreneurs on the leading edge of new and innovative technologies can benefit from a location that complies with the highest standards needed for the industry. To that end, GVI is situated in a newly constructed facility that houses both the GVI research and management staff, and several client companies. The custom designed building provides access to business structure and state of the art equipment.Building ValueA proven track record and an experienced and talented team make Genesys Venture Inc. a unique vehicle for developing innovative ventures.

We're your source for everything Ford in Mid-Town Ford, from Sales & Service to Parts. Give us a call or stop by to find your perfect vehicle, or for anything you need on the one you already have.

Murray Chevrolet is a dealership in Winnipeg, MB, specializing in the sale of new and used Chevrolet vehicles, offering comprehensive services including financing, maintenance, and collision repair.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.